1887

Abstract

Carbapenem-resistant Gram-negative bacteria (CR-GNB) are a major source of nosocomial infections worldwide. In this study, the ability of a loop-mediated isothermal amplification (LAMP)-based method (Isoplex CRE-ART) to rapidly detect carbapenemase-encoding genes , , , , , and in 231 carbapenem-resistant and isolates was investigated. The accuracy of the LAMP test was compared to results of molecular isolate characterization using a Laboratory Developed Test multiplex carbapenemase PCR assay. The LAMP test correctly identified the presence of on-panel carbapenemases with a sensitivity of 99.16 % [95 % confidence interval (CI): 95.39–99.96 %] and a specificity of 98.21 % (95 % CI: 93.72–99.68 %) in 60 min. Our findings suggest that the Isoplex CRE-ART assay is able to rapidly identify carbapenemase genes in CR-GNB and improves options for pathogen characterization in the context of clinical microbiological and infection control diagnostics.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001379
2021-07-12
2021-07-27
Loading full text...

Full text loading...

References

  1. Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT et al. European survey of carbapenemase-producing Enterobacteriaceae working, occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 2017; 17:153–163 [View Article]
    [Google Scholar]
  2. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791–1798 [View Article] [PubMed]
    [Google Scholar]
  3. Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019; 19:56–66
    [Google Scholar]
  4. Dautzenberg MJ, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H et al. The association between colonization with carbapenemase-producing Enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med 2015; 43:1170–1177
    [Google Scholar]
  5. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538–582 [View Article] [PubMed]
    [Google Scholar]
  6. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995; 20:790–796 [View Article] [PubMed]
    [Google Scholar]
  7. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46:1254–1263 [View Article] [PubMed]
    [Google Scholar]
  8. Righi E, Peri AM, Harris PN, Wailan AM, Liborio M et al. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother 2017; 72:668–677 [View Article] [PubMed]
    [Google Scholar]
  9. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 2014; 44:51–56 [View Article] [PubMed]
    [Google Scholar]
  10. Tamma PD, Opene BNA, Gluck A, Chambers KK, Carroll KC et al. Comparison of 11 phenotypic assays for accurate detection of carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 2017; 55:1046–1055 [View Article] [PubMed]
    [Google Scholar]
  11. Tamma PD, Simner PJ. Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol 2018; 56:11 [View Article]
    [Google Scholar]
  12. van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ et al. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods. PLoS One 2015; 10:e0123690 [View Article] [PubMed]
    [Google Scholar]
  13. Dortet L, Poirel L, Nordmann P. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother 2012; 56:6437–6440 [View Article] [PubMed]
    [Google Scholar]
  14. Marchaim D, Navon-Venezia S, Leavitt A, Chmelnitsky I, Schwaber MJ et al. Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital. Infect Control Hosp Epidemiol 2007; 28:945–950 [View Article] [PubMed]
    [Google Scholar]
  15. Marchaim D, Navon-Venezia S, Schwartz D, Tarabeia J, Fefer I et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007; 45:1551–1555 [View Article] [PubMed]
    [Google Scholar]
  16. Anandan S, Damodaran S, Gopi R, Bakthavatchalam YD, Veeraraghavan B. Rapid screening for carbapenem resistant organisms: Current results and future approaches. J Clin Diagn Res 2015; 9:DM01–3 [View Article] [PubMed]
    [Google Scholar]
  17. Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Front Microbiol 2019; 10:80 [View Article] [PubMed]
    [Google Scholar]
  18. Mosqueda N, Espinal P, Cosgaya C, Viota S, Plasensia V et al. Globally expanding carbapenemase finally appears in Spain: nosocomial outbreak of Acinetobacter baumannii producing plasmid-encoded OXA-23 in Barcelona, Spain. Antimicrob Agents Chemother 2013; 57:5155–5157 [View Article] [PubMed]
    [Google Scholar]
  19. Zander E, Bonnin RA, Seifert H, Higgins PG. Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii. Antimicrob Agents Chemother 2014; 58:2704–2708 [View Article] [PubMed]
    [Google Scholar]
  20. Vergara A, Zboromyrska Y, Mosqueda N, Morosini MI, Garcia-Fernandez S et al. Evaluation of a loop-mediated isothermal amplification-based methodology to detect carbapenemase carriage in Acinetobacter clinical isolates. Antimicrob Agents Chemother 2014; 58:7538–7540 [View Article] [PubMed]
    [Google Scholar]
  21. Asar L, Pfefferle S, Lutgehetmann M, Hoffmann A, Katchanov J et al. Influence of local epidemiology on the performance of common colistin drug susceptibility testing methods. PLoS One 2019; 14:e0217468 [View Article] [PubMed]
    [Google Scholar]
  22. van der Zee A, Roorda L, Bosman G, Fluit AC, Hermans M et al. Multi-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC. BMC Infect Dis 2014; 14:27 [View Article] [PubMed]
    [Google Scholar]
  23. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27:351–353 [View Article] [PubMed]
    [Google Scholar]
  24. Garcia-Fernandez S, Morosini MI, Marco F, Gijon D, Vergara A et al. Evaluation of the eazyplex(R) SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals. J Antimicrob Chemother 2015; 70:1047–1050 [View Article] [PubMed]
    [Google Scholar]
  25. Lahiri S, Venkataraman R, Jagan A, Deshmukh G, Patra S et al. Evaluation of LAMP-based assays for carbapenemase genes. J Med Microbiol 2019; 68:1431–1437 [View Article] [PubMed]
    [Google Scholar]
  26. The European Centre for Disease Prevention and Control Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-NET; 2018 https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2018.pdf
  27. Ben-Chetrit E, Wiener-Well Y, Lesho E, Kopuit P, Broyer C et al. An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital. Crit Care 2018; 22:319 [View Article] [PubMed]
    [Google Scholar]
  28. Bianco A, Quirino A, Giordano M, Marano V, Rizzo C et al. Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy. BMC Infect Dis 2016; 16:747 [View Article] [PubMed]
    [Google Scholar]
  29. Zhao Y, Hu K, Zhang J, Guo Y, Fan X et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China. BMC Infect Dis 2019; 19:452 [View Article] [PubMed]
    [Google Scholar]
  30. Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Glob Infect Dis 2010; 2:291–304 [View Article] [PubMed]
    [Google Scholar]
  31. McMullen AR, Yarbrough ML, Wallace MA, Shupe A, Burnham CD. Evaluation of genotypic and phenotypic methods to detect carbapenemase production in Gram-negative bacilli. Clin Chem 2017; 63:723–730 [View Article] [PubMed]
    [Google Scholar]
  32. Baeza LL, Pfennigwerth N, Greissl C, Gottig S, Saleh A et al. Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm. Clin Microbiol Infect 25:1286 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001379
Loading
/content/journal/jmm/10.1099/jmm.0.001379
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error